InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,220.99
(
-0.03%
)
US TECH 100
17,717.20
(
0.20%
)
Dow Jones
39,456.38
(
-0.14%
)
Brent Oil
83.27
(
1.07%
)
Bitcoin
63,045.38
(
2.60%
)
Post# of 81
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Sheep

Send PM Follow Ignore
Followers 114
Posts 6021
Boards Moderated 3
Alias Born 09/16/2009

Sheep

Re: coupleofsnipes post# 62

Thursday, 08/14/2014 9:47:05 AM

Thursday, August 14, 2014 9:47:05 AM

Post# of 81
Just found it as well:
http://www.finnewsnetwork.com.au/archives/finance_news_network77564.html

Shares in QRxPharma Limited (ASX:QRX) have plunged more than 50 per cent on the news they will halt development of Moxduo. The pharmaceutical company announced in late May the pain drug had failed to receive approval from the US Food and Drug Administration. The company says the time and cost of further development would not be commercially justifiable. Shares in QRxPharma are trading down 50.68 per cent at $0.04

Email: sheepery@gmail.com

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up